Eli Lilly and Company News - June 2026
Eli Lilly Surges 4.6% on Weight-Loss Drug Euphoria and Big-Money Buying — But Can the Stock Keep Outrunning Its Own Hype?
Shares of Eli Lilly jumped 4.6% to $1,127.99 on June 4, snapping a week-long slide that saw the stock drop from $1,126.80 to $1,064.15 in just five sessions....
🟢 Eli Lilly is trading 4.6% up today on a new $1.9B genetic medicine deal and a Weight Watchers partnership
Eli Lilly and Company is trading 4.6% up at $1127.99 following the announcement of a major research partnership and expanded access for its weight-loss drug...
Eli Lilly inks $4.2B in Asian drug deals to bolster pipeline
Eli Lilly and Company signed two significant licensing agreements in Asia on June 1, 2026. The company partnered with China’s Haisco Pharmaceutical in a...